 | Up a level |
Pereyra, D.; Rumpf, B.; Ammann, M.; Perrodin, S. F.; Tamandl, D.; Haselmann, C.; Stift, J.; Brostjan, C.; Laengle, F.; Beldi, G.; Gruenberger, T.; Starlinger, P. (2019). The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy. Annals of surgical oncology, 26(3), pp. 791-799. Springer 10.1245/s10434-018-07125-6
Starlinger, P.; Haegele, S.; Braeuer, P.; Oehlberger, L.; Primavesi, F.; Kohler, Andreas; Offensperger, F.; Pereyra, D.; Ferlitsch, A.; Beldi, Guido; Staettner, S.; Brostjan, C.; Gruenberger, T. (2017). Preoperative von willebrand factor – antigen predicts clinical outcome after liver resection: a prospective, international, multicenter trial. Journal of hepatology, 66(1), S194-S194. Elsevier 10.1016/S0168-8278(17)30679-7
